Status:
COMPLETED
Tolerability and Safety of An Infant Formula
Lead Sponsor:
Perrigo Nutritionals
Conditions:
Milk Hypersensitivity
Eligibility:
All Genders
1-12 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate an extensively hydrolyzed formula in infants with cow's milk allergy.
Eligibility Criteria
Inclusion
- clinically diagnosed CMA
- \</= 12 weeks at time of study entry
- full-term infant
- must be willing to use provided formula as sole source of nutrition
- other than CMA, infant must be otherwise healthy
Exclusion
- underlying or confounding gastrointestinal abnormalities
- infants born from an addictive situation, HIV positive
- if parent/guardian is considered likely to be non-compliant with the protocol requirements
Key Trial Info
Start Date :
August 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT00938483
Start Date
August 1 2007
End Date
January 1 2009
Last Update
July 15 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.